Evidence map›Paper›PMID 40733556›Full record

ArticleViruses2025

Therapeutic Optimization of

Sara Bolognini, Caterina Ferretti, Claudia Campobasso, Elisabetta Trovato, Magda Marchetti, Laura Rindi, Arianna Tavanti, Mariagrazia Di Luca

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Antibacterial Efficacy ofPathogens (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sara BologniniDepartment of Biology, University of Pisa, 56126 Pisa, Italy.ORCID 0009-0007-4574-4512
Caterina FerrettiDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.
Claudia CampobassoDepartment of Biology, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0001-7362-6117
Elisabetta TrovatoDepartment of Biology, University of Pisa, 56126 Pisa, Italy.
Magda MarchettiNational Centre for Innovative Technologies in Public Health, National Institute of Health, 00161 Rome, Italy.ORCID 0000-0003-3871-4976
Laura RindiDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0001-7036-1192
Arianna TavantiDepartment of Biology, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0001-5791-686X
Mariagrazia Di LucaDepartment of Biology, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0002-0688-034X

Funding

Italian Ministry of Health Project ID: T4-AN-07 CUP: I53C22001300001PNRR THE e Tuscany Health Ecosystem Project code: ECS00000017; CUP I53C22000780001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Phage TherapyPseudomonas aeruginosaPseudomonas InfectionsPseudomonas PhagesAnti-Bacterial AgentsDirected Molecular EvolutionGenome, ViralHumansMicrobial Sensitivity TestsMyoviridaeAnti-Bacterial Agentscystic fibrosisdirect phage evolutionlung infectionphage–antibiotic combinationphage therapy

Identifiers

PMID40733556
PMCPMC12300175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.